Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

MSD updates Univadis, adds apps

New UK version of its HCP website will allow users to personalise the portal

Merck Sharp Dohme MSD Univadis appsMerck Sharp & Dohme (MSD) has relaunched the UK version of its healthcare professional website Univadis.

The new site adds a medical app library that allows users to personalise the portal, choosing from specialist disease information and clinical interests for more than 50 specialties.

Deepak Khanna, MSD's managing director, said: "Since the release of The Merck Manual more than 100 years ago, MSD has been committed to supporting doctors and healthcare professionals by providing non-promotional health information.

“MSD's ongoing dedication to providing high quality and state-of-the-art resources to medical audiences is exemplified by the re-development of Univadis, and is in line with MSD's vision of delivering innovative health solutions.”

Set up in 2001, Univadis.co.uk is free for healthcare professionals (HCPs) to access and includes content from leading medical journals such as The Lancet and the British Medical Journal.

The site's new range of medical applications offers access to medical news, accredited education courses, disease information and point-of-care tools.

Editor in Chief of Univadis in the UK, Dr Harry Brown says: “For all healthcare professionals, medical education is a vital aspect of ensuring the best patient care possible. 

“By offering high quality and accredited online education courses and other valuable resources to the medical community, Univadis can really make a difference to many practitioners in the United Kingdom.”

MSD is also hoping to carve out a niche for Univadis as a point-of-care tool for use during patient consultations, and the site now includes a bank more than 58,000 medical images and wide-ranging disease information the company hopes will “help inform patient-doctor conversations”.

In addition to its uses for healthcare professionals, MSD's parent company Merck & Co has talked in the past about how important the site is for its future, with increasing levels of trust with HCPs one of its key aims.

13th May 2013

From: Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....